Long-Term Bets: Why Analysts Are Bullish on Reliance [RELIANCE] & Axis Bank [AXISBANK] for 2026

For investors with a horizon stretching to 2026, leading market analysts and prominent brokerage firms are signaling promising opportunities in the Indian equity market. A recent collation of recommendations highlights a selection of stocks identified for their strong fundamentals and potential to deliver substantial long-term returns, with estimates ranging from 10% to 30%. Among the top picks garnering significant attention are the diversified conglomerate Reliance Industries [RELIANCE] and the established private sector lender Axis Bank [AXISBANK].

Reliance Industries [RELIANCE], a titan across multiple sectors, continues to be a favourite among analysts. The company’s strategic pivots and diversified revenue streams – spanning its traditional oil-to-chemicals business, its rapidly expanding retail arm, the dominant telecom presence through Jio Platforms, and its ambitious foray into new energy ventures – position it strongly for future growth. Experts believe that its integrated ecosystem and continuous innovation will drive value creation over the next few years, making it a compelling 'Buy' for investors seeking capital appreciation by 2026.

Similarly, Axis Bank [AXISBANK] has emerged as a preferred choice in the financial services sector. The private banking major is lauded for its consistent balance sheet growth, improving asset quality, and strategic focus on digital transformation. Analysts anticipate that Axis Bank's robust retail franchise, expanding customer base, and prudent risk management practices will enable it to capitalize on India's economic growth trajectory. The 'Buy' recommendation for Axis Bank underscores confidence in its ability to deliver healthy returns for long-term shareholders.

These recommendations, originating from various top brokerage firms, are based on comprehensive fundamental analysis, sector outlooks, and macroeconomic factors. Investors looking to build a resilient portfolio for the medium to long term might find these insights valuable. The suggested timeframe for these 'Buy' calls extends to 2026, aligning with a strategy focused on patient capital deployment.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. StockTips.in is not a SEBI-registered investment advisor.